Affiliation:
1. Universidade Estadual do Ceará, Brazil
2. Universidade Federal Rural da Amazônia, Brazil
Abstract
ABSTRACT: Obesity is considered a chronic inflammatory process that is related to metabolic impairment, respiratory distress, and cardiovascular disease. In cats, few studies have evaluated the implications of obesity on the cardiovascular system, and the existing literature is controversial. Therefore, the aim of this study is to detect pressure, electrocardiographic, and morphofunctional changes in overweight and obese cats. After clinical and laboratory evaluation, 45 animals were selected for the study. Cats were separated according to body condition score (BCS) into three groups (control, overweight, and obese). All animals underwent blood pressure measurement, electrocardiogram, and transthoracic echocardiogram. Results are presented as mean ± standard deviation (SD). Data were considered statistically significant at p<0.05. GraphPad Prism® 7.04 software was used for statistical analyses. Mean arterial pressure in obese cats was higher than in animals with ideal weight (CT 123.60 ± 8.97mmHg vs OB 143.00 ± 22.12mmHg, p<0.0138), but hypertension was not detected. On the electrocardiogram, P wave duration (CT 33.67 ± 1.56ms vs OB 37.76 ± 2.76ms; p<0.0003) and QRS complex (CT 48.14 ± 2.56ms vs OB 54.48 ± 5.51ms; p<0.002) were significantly higher in the obese group. There were no significant echocardiographic changes. There was a direct correlation between blood pressure and BCS (r:0.36, p<0.01). The P wave was positively correlated with the BCS (r:0.56, p<0.0001). Likewise, the QRS complex correlated directly with the BCS (r:0.52, p<0.0003). The results indicate cat obesity can directly affect the cardiovascular system, promoting pressure and electrocardiographic changes. Therefore, monitoring the cardiovascular system of cats with obesity is essential.
Reference46 articles.
1. Two-dimensional echocardiographic evaluation of the feline left atrium;Abbott J.A.;J. Vet. Intern. Med.,2006
2. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction;Achari A.E.;Int. J. Mol. Sci.,2017
3. ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats;Acierno M.J.;J. Vet. Intern. Med.,2018
4. Recent advances in the relationship between obesity, inflammation, and insulin resistance;Bastard J.-P.;Eur. Cytokine Netw.,2006
5. Evaluation of the white-coat effect in cats;Belew A.M.;J. Vet. Intern. Med.,1999